Pien Huang
Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.
Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.
-
The CDC recently lifted some of its mask guidance for fully vaccinated people. So is it safe to go out now? NPR answers your pressing questions.
-
The Centers of Disease control and Prevention is recommending the Pfizer COVID-19 vaccine for kids 12 and up, clearing the way for it to be given to teens and preteens this week.
-
The Food and Drug Administration has extended authorization for the Pfizer COVID-19 vaccine to include adolescents age 12-15. Those young people have missed months of school and time with friends.
-
Having reviewd the data on trials, the U.S. Food and Drug Administration is expected to approve the use of the Pfizer vaccine on children as young as 12.
-
Federal health officials have lifted the pause on use of the Johnson & Johnson vaccine. States can resume distributing it, now with a warning about rare complications involving blood clots.
-
The CDC's vaccine advisory committee met Friday to decide how to proceed with the Johnson & Johnson vaccine, which is possibly linked to rare, dangerous side effects.
-
A pause in the distribution of the Johnson & Johnson vaccine will last at least another week, even as eligibility for coronavirus vaccines expand. What impact will the pause have on inoculations?
-
The CDC's independent vaccine advisory group is reviewing the safety of the Johnson & Johnson COVID-19 vaccine. The government recommended a pause in administering the vaccine during the review.
-
The pause of administering the Johnson & Johnson vaccine could affect the rollout of COVID-19 vaccines in the U.S., especially since it's so practical for rural areas.
-
A year into the pandemic, the agency's staffers reflect on what it's been like to fight the biggest public health battle in their history and how they're working to rebuild public trust in science. -
The process to sign up for COVID-19 vaccines varies by place so NPR created a tool to help you understand how things work in your state and connect you with local resources.
-
With vaccine still scarce, and eligibility differing from place to place, some people have easier access to "extra" doses than others. Careful, ethicists warn. Going out of turn is a slippery slope.
